Celldex Therapeutics, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.04 | — | — | Miss |
| Q1 FY2026 | $-1.13 | — | — | Miss |
| Q12026 FY2026 | $-1.10 | $-1.18 | -7.3% | Miss |
| 2026-02-26 | $-1.00 | — | — | Miss |
Back to CLDX overview · CLDX holders · CLDX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.